Adams M - Search Results

1

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Lipetz C, Evans AS, Mason M. Adams M, et al. Vaccine. 2001 Mar 21;19(17-19):2549-56. doi: 10.1016/s0264-410x(00)00488-6. Vaccine. 2001. PMID: 11257391 Review.

2

Clinical studies of human papilloma vaccines in cervical cancer.

Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Evans AS, Mason M. Adams M, et al. Adv Exp Med Biol. 2001;495:419-27. doi: 10.1007/978-1-4615-0685-0_61. Adv Exp Med Biol. 2001. PMID: 11774604 No abstract available.

3

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

Adams M, Navabi H, Jasani B, Man S, Fiander A, Evans AS, Donninger C, Mason M. Adams M, et al. Vaccine. 2003 Jan 30;21(7-8):787-90. doi: 10.1016/s0264-410x(02)00599-6. Vaccine. 2003. PMID: 12531360 Review.

4

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer.

Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, Jasani B, Mason MD. Adams M, et al. Vaccine. 2005 Mar 18;23(17-18):2374-8. doi: 10.1016/j.vaccine.2005.01.014. Vaccine. 2005. PMID: 15755631

5

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A. Adams M, et al. Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18. Vaccine. 2007. PMID: 17292517 Review.

6

A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.

Navabi H, Jasani B, Reece A, Clayton A, Tabi Z, Donninger C, Mason M, Adams M. Navabi H, et al. Among authors: adams m. Vaccine. 2009 Jan 1;27(1):107-15. doi: 10.1016/j.vaccine.2008.10.024. Epub 2008 Oct 31. Vaccine. 2009. PMID: 18977262

7

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.

Jasani B, Navabi H, Adams M. Jasani B, et al. Among authors: adams m. Vaccine. 2009 May 26;27(25-26):3401-4. doi: 10.1016/j.vaccine.2009.01.071. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200817

8

Prophylactic HPV vaccination for women over 18 years of age.

Adams M, Jasani B, Fiander A. Adams M, et al. Vaccine. 2009 May 26;27(25-26):3391-4. doi: 10.1016/j.vaccine.2009.01.067. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200838

9

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

Borysiewicz LK, Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, Evans AS, Adams M, Stacey SN, Boursnell ME, Rutherford E, Hickling JK, Inglis SC. Borysiewicz LK, et al. Among authors: adams m. Lancet. 1996 Jun 1;347(9014):1523-7. doi: 10.1016/s0140-6736(96)90674-1. Lancet. 1996. PMID: 8684105 Clinical Trial.

10

Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma.

Jasani B, Coleman S, Butchart E, Evans EM, Adams M, Mason M, Gibbs A, Tabi Z. Jasani B, et al. Among authors: adams m. Vaccine. 2005 Mar 18;23(17-18):2399-402. doi: 10.1016/j.vaccine.2005.01.019. Vaccine. 2005. PMID: 15755635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,974 results

Search Page

Filters